Dr. Gina Ogilvie is one of fifteen UBC faculty members announced by the Royal Society of Canada (RSC) as new Fellows and Members of the College of New Scholars, Artists and Scientists in September 2024. Fellows and College Members are officially inducted into the RSC at the annual Celebration of Excellence and Engagement in November. Learn more about her research below.
Gina Ogilvie is a Professor and Tier 1 Canada Research Chair in the Global Control of HPV (human papillomavirus)-Related Disease and Cancer at the University of British Columbia. Her career is dedicated to eliminating cervical cancer in Canada and globally. She is internationally recognized for her research on reduced dosing of the HPV vaccine, improving HPV vaccine uptake, and innovative cervical screening methods, which have transformed health policy globally.